Ikena Oncology Stock Alpha and Beta Analysis
| IKNA Stock | USD 1.34 0.02 1.47% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Ikena Oncology. It also helps investors analyze the systematic and unsystematic risks associated with investing in Ikena Oncology over a specified time horizon. Remember, high Ikena Oncology's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Ikena Oncology's market risk premium analysis include:
Beta 0.49 | Alpha (0.23) | Risk 2.74 | Sharpe Ratio (0.1) | Expected Return (0.27) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Ikena |
Ikena Oncology Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Ikena Oncology market risk premium is the additional return an investor will receive from holding Ikena Oncology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Ikena Oncology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Ikena Oncology's performance over market.| α | -0.23 | β | 0.49 |
Ikena Oncology expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Ikena Oncology's Buy-and-hold return. Our buy-and-hold chart shows how Ikena Oncology performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Ikena Oncology Market Price Analysis
Market price analysis indicators help investors to evaluate how Ikena Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ikena Oncology shares will generate the highest return on investment. By understating and applying Ikena Oncology stock market price indicators, traders can identify Ikena Oncology position entry and exit signals to maximize returns.
Ikena Oncology Return and Market Media
The median price of Ikena Oncology for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 1.5 with a coefficient of variation of 6.97. The daily time series for the period is distributed with a sample standard deviation of 0.11, arithmetic mean of 1.51, and mean deviation of 0.09. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Boston biotech opts for reverse merger with San Diego company | 12/24/2024 |
2 | Inmagene Bio charts backdoor to U.S. listing with offshore acquisition - Bamboo Works | 01/02/2025 |
3 | Acquisition by Orbimed Advisors Llc of 353192 shares of Ikena Oncology subject to Rule 16b-3 | 01/17/2025 |
4 | Acquisition by Zhang Xiaoyan Michelle of 964 shares of Ikena Oncology at 2.1462 subject to Rule 16b-3 | 01/30/2025 |
5 | Ikena Oncology, Inc. SEC 10-K Report - TradingView | 03/06/2025 |
About Ikena Oncology Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Ikena or other stocks. Alpha measures the amount that position in Ikena Oncology has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Debt Per Share | 0.22 | 0.26 | 0.16 | 0.15 | Revenue Per Share | 0.43 | 0.22 | 0.2 | 0.29 |
Ikena Oncology Upcoming Company Events
As portrayed in its financial statements, the presentation of Ikena Oncology's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ikena Oncology's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Ikena Oncology's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Ikena Oncology. Please utilize our Beneish M Score to check the likelihood of Ikena Oncology's management manipulating its earnings.
| 12th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Ikena Oncology
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Ikena Oncology Backtesting, Ikena Oncology Valuation, Ikena Oncology Correlation, Ikena Oncology Hype Analysis, Ikena Oncology Volatility, Ikena Oncology History and analyze Ikena Oncology Performance. For information on how to trade Ikena Stock refer to our How to Trade Ikena Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Ikena Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.